Global Non-Benzodiazepines Supply, Demand and Key Producers, 2026-2032
The global Non-Benzodiazepines market size is expected to reach $ 1479 million by 2032, rising at a market growth of 2.8% CAGR during the forecast period (2026-2032).
Non-benzodiazepines are prescription sedative-hypnotics primarily represented by zolpidem, zopiclone, eszopiclone, and zaleplon. Although chemically distinct from conventional benzodiazepines, they mainly enhance GABAergic inhibitory neurotransmission through positive allosteric modulation of benzodiazepine recognition sites on GABAA receptors and are used to treat sleep-onset difficulty, frequent nocturnal awakening, early awakening, and sleep-maintenance insomnia. Major dosage forms include immediate-release tablets, extended-release tablets, capsules, sublingual tablets, orally disintegrating tablets, and oral sprays. Upstream inputs mainly include zolpidem tartrate, zopiclone, eszopiclone, and zaleplon active pharmaceutical ingredients, together with fillers, disintegrants, coating materials, extended-release excipients, capsule shells, spray-pump components, and pharmaceutical packaging materials. Downstream customers mainly include general hospitals, psychiatric hospitals, sleep clinics, primary care institutions, retail pharmacies, regulated online prescription platforms, and pharmaceutical distributors. Competition is intense in standard generic tablets, while extended-release tablets, sublingual products, oral sprays, and established branded products retain higher added value, with an overall gross margin generally ranging from approximately 45% to 68%.
From the current market perspective, non-benzodiazepines form a mature market dominated by zolpidem, with zopiclone and eszopiclone representing important secondary segments and zaleplon accounting for a relatively small share. All major active ingredients are exposed to generic competition, and standard tablets are supplied by numerous manufacturers. Zolpidem and eszopiclone are more prominent in the United States, while zopiclone is widely used in Europe, Canada, and parts of Asia.
Looking ahead, market innovation will focus mainly on dosage-form optimization, lower-dose treatment, precision dosing, and medication safety. Standard tablets will continue to account for most volume, while extended-release tablets, sublingual tablets, orally disintegrating tablets, oral sprays, and low-dose products for middle-of-the-night awakening offer greater differentiation. Manufacturers will place greater emphasis on next-day impairment, complex sleep behaviors, falls in older patients, and dependence management.
Key market drivers include faster-paced lifestyles, psychological stress, population aging, increasing diagnosis of insomnia, and greater awareness of sleep health. These medicines have rapid onset, broad physician familiarity, and widespread generic availability. Their treatment costs are generally lower than those of newer-mechanism medicines such as orexin receptor antagonists, supporting continued use in hospitals, primary care institutions, and retail prescription markets.
The main constraints include next-day somnolence, cognitive and motor impairment, falls, tolerance, dependence, withdrawal, and complex sleep behaviors such as sleepwalking and sleep driving. Many jurisdictions impose prescription-duration limits, dose restrictions, and controlled-drug requirements. Cognitive behavioral therapy, digital sleep interventions, orexin receptor antagonists, and other new-mechanism insomnia treatments will also divert some chronic-insomnia patients.
This report studies the global Non-Benzodiazepines demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non-Benzodiazepines, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-Benzodiazepines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non-Benzodiazepines total market, 2021-2032, (USD Million)
Global Non-Benzodiazepines total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Non-Benzodiazepines total market, key domestic companies, and share, (USD Million)
Global Non-Benzodiazepines revenue by player, revenue and market share 2021-2026, (USD Million)
Global Non-Benzodiazepines total market by Type, CAGR, 2021-2032, (USD Million)
Global Non-Benzodiazepines total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Non-Benzodiazepines market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cosette Pharmaceuticals, Sanofi, Sumitomo Pharma, Teva Pharmaceutical Industries, Viatris, Sandoz, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Aurobindo Pharma, Lupin, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Non-Benzodiazepines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Non-Benzodiazepines Market, By Region:
1. How big is the global Non-Benzodiazepines market?
2. What is the demand of the global Non-Benzodiazepines market?
3. What is the year over year growth of the global Non-Benzodiazepines market?
4. What is the total value of the global Non-Benzodiazepines market?
5. Who are the Major Players in the global Non-Benzodiazepines market?
6. What are the growth factors driving the market demand?
Non-benzodiazepines are prescription sedative-hypnotics primarily represented by zolpidem, zopiclone, eszopiclone, and zaleplon. Although chemically distinct from conventional benzodiazepines, they mainly enhance GABAergic inhibitory neurotransmission through positive allosteric modulation of benzodiazepine recognition sites on GABAA receptors and are used to treat sleep-onset difficulty, frequent nocturnal awakening, early awakening, and sleep-maintenance insomnia. Major dosage forms include immediate-release tablets, extended-release tablets, capsules, sublingual tablets, orally disintegrating tablets, and oral sprays. Upstream inputs mainly include zolpidem tartrate, zopiclone, eszopiclone, and zaleplon active pharmaceutical ingredients, together with fillers, disintegrants, coating materials, extended-release excipients, capsule shells, spray-pump components, and pharmaceutical packaging materials. Downstream customers mainly include general hospitals, psychiatric hospitals, sleep clinics, primary care institutions, retail pharmacies, regulated online prescription platforms, and pharmaceutical distributors. Competition is intense in standard generic tablets, while extended-release tablets, sublingual products, oral sprays, and established branded products retain higher added value, with an overall gross margin generally ranging from approximately 45% to 68%.
From the current market perspective, non-benzodiazepines form a mature market dominated by zolpidem, with zopiclone and eszopiclone representing important secondary segments and zaleplon accounting for a relatively small share. All major active ingredients are exposed to generic competition, and standard tablets are supplied by numerous manufacturers. Zolpidem and eszopiclone are more prominent in the United States, while zopiclone is widely used in Europe, Canada, and parts of Asia.
Looking ahead, market innovation will focus mainly on dosage-form optimization, lower-dose treatment, precision dosing, and medication safety. Standard tablets will continue to account for most volume, while extended-release tablets, sublingual tablets, orally disintegrating tablets, oral sprays, and low-dose products for middle-of-the-night awakening offer greater differentiation. Manufacturers will place greater emphasis on next-day impairment, complex sleep behaviors, falls in older patients, and dependence management.
Key market drivers include faster-paced lifestyles, psychological stress, population aging, increasing diagnosis of insomnia, and greater awareness of sleep health. These medicines have rapid onset, broad physician familiarity, and widespread generic availability. Their treatment costs are generally lower than those of newer-mechanism medicines such as orexin receptor antagonists, supporting continued use in hospitals, primary care institutions, and retail prescription markets.
The main constraints include next-day somnolence, cognitive and motor impairment, falls, tolerance, dependence, withdrawal, and complex sleep behaviors such as sleepwalking and sleep driving. Many jurisdictions impose prescription-duration limits, dose restrictions, and controlled-drug requirements. Cognitive behavioral therapy, digital sleep interventions, orexin receptor antagonists, and other new-mechanism insomnia treatments will also divert some chronic-insomnia patients.
This report studies the global Non-Benzodiazepines demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non-Benzodiazepines, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-Benzodiazepines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non-Benzodiazepines total market, 2021-2032, (USD Million)
Global Non-Benzodiazepines total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Non-Benzodiazepines total market, key domestic companies, and share, (USD Million)
Global Non-Benzodiazepines revenue by player, revenue and market share 2021-2026, (USD Million)
Global Non-Benzodiazepines total market by Type, CAGR, 2021-2032, (USD Million)
Global Non-Benzodiazepines total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Non-Benzodiazepines market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cosette Pharmaceuticals, Sanofi, Sumitomo Pharma, Teva Pharmaceutical Industries, Viatris, Sandoz, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Aurobindo Pharma, Lupin, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Non-Benzodiazepines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Non-Benzodiazepines Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Zolpidem
- Zopiclone
- Eszopiclone
- Zaleplon
- Tablets
- Capsules
- Other
- Originator Drugs
- Generic Drugs
- Hospital
- Clinic
- Others
- Cosette Pharmaceuticals
- Sanofi
- Sumitomo Pharma
- Teva Pharmaceutical Industries
- Viatris
- Sandoz
- Sun Pharmaceutical Industries
- Dr. Reddy's Laboratories
- Aurobindo Pharma
- Lupin
- Torrent Pharmaceuticals
- Jiangsu Nhwa Pharmaceutical
- Shanghai Pharmaceuticals
- Qilu Pharmaceutical
- Chengdu Kanghong Pharmaceutical Group
1. How big is the global Non-Benzodiazepines market?
2. What is the demand of the global Non-Benzodiazepines market?
3. What is the year over year growth of the global Non-Benzodiazepines market?
4. What is the total value of the global Non-Benzodiazepines market?
5. Who are the Major Players in the global Non-Benzodiazepines market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Non-Benzodiazepines Introduction
1.2 World Non-Benzodiazepines Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Non-Benzodiazepines Total Market by Region (by Headquarter Location)
1.3.1 World Non-Benzodiazepines Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Non-Benzodiazepines Revenue (2021-2032)
1.3.3 China Based Company Non-Benzodiazepines Revenue (2021-2032)
1.3.4 Europe Based Company Non-Benzodiazepines Revenue (2021-2032)
1.3.5 Japan Based Company Non-Benzodiazepines Revenue (2021-2032)
1.3.6 South Korea Based Company Non-Benzodiazepines Revenue (2021-2032)
1.3.7 ASEAN Based Company Non-Benzodiazepines Revenue (2021-2032)
1.3.8 India Based Company Non-Benzodiazepines Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-Benzodiazepines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Non-Benzodiazepines Consumption Value (2021-2032)
2.2 World Non-Benzodiazepines Consumption Value by Region
2.2.1 World Non-Benzodiazepines Consumption Value by Region (2021-2026)
2.2.2 World Non-Benzodiazepines Consumption Value Forecast by Region (2027-2032)
2.3 United States Non-Benzodiazepines Consumption Value (2021-2032)
2.4 China Non-Benzodiazepines Consumption Value (2021-2032)
2.5 Europe Non-Benzodiazepines Consumption Value (2021-2032)
2.6 Japan Non-Benzodiazepines Consumption Value (2021-2032)
2.7 South Korea Non-Benzodiazepines Consumption Value (2021-2032)
2.8 ASEAN Non-Benzodiazepines Consumption Value (2021-2032)
2.9 India Non-Benzodiazepines Consumption Value (2021-2032)
3 WORLD NON-BENZODIAZEPINES COMPANIES COMPETITIVE ANALYSIS
3.1 World Non-Benzodiazepines Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Non-Benzodiazepines Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Non-Benzodiazepines in 2025
3.2.3 Global Concentration Ratios (CR8) for Non-Benzodiazepines in 2025
3.3 Non-Benzodiazepines Company Evaluation Quadrant
3.4 Non-Benzodiazepines Market: Overall Company Footprint Analysis
3.4.1 Non-Benzodiazepines Market: Region Footprint
3.4.2 Non-Benzodiazepines Market: Company Product Type Footprint
3.4.3 Non-Benzodiazepines Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Non-Benzodiazepines Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Non-Benzodiazepines Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Non-Benzodiazepines Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Non-Benzodiazepines Consumption Value Comparison
4.2.1 United States VS China: Non-Benzodiazepines Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Non-Benzodiazepines Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Non-Benzodiazepines Companies and Market Share, 2021-2026
4.3.1 United States Based Non-Benzodiazepines Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Non-Benzodiazepines Revenue, (2021-2026)
4.4 China Based Companies Non-Benzodiazepines Revenue and Market Share, 2021-2026
4.4.1 China Based Non-Benzodiazepines Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Non-Benzodiazepines Revenue, (2021-2026)
4.5 Rest of World Based Non-Benzodiazepines Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Non-Benzodiazepines Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Non-Benzodiazepines Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Non-Benzodiazepines Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Zolpidem
5.2.2 Zopiclone
5.2.3 Eszopiclone
5.2.4 Zaleplon
5.3 Market Segment by Type
5.3.1 World Non-Benzodiazepines Market Size by Type (2021-2026)
5.3.2 World Non-Benzodiazepines Market Size by Type (2027-2032)
5.3.3 World Non-Benzodiazepines Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DOSAGE FORM
6.1 World Non-Benzodiazepines Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage Form
6.2.1 Tablets
6.2.2 Capsules
6.2.3 Other
6.3 Market Segment by Dosage Form
6.3.1 World Non-Benzodiazepines Market Size by Dosage Form (2021-2026)
6.3.2 World Non-Benzodiazepines Market Size by Dosage Form (2027-2032)
6.3.3 World Non-Benzodiazepines Market Size Market Share by Dosage Form (2027-2032)
7 MARKET ANALYSIS BY PRODUCT STATUS
7.1 World Non-Benzodiazepines Market Size Overview by Product Status: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Status
7.2.1 Originator Drugs
7.2.2 Generic Drugs
7.3 Market Segment by Product Status
7.3.1 World Non-Benzodiazepines Market Size by Product Status (2021-2026)
7.3.2 World Non-Benzodiazepines Market Size by Product Status (2027-2032)
7.3.3 World Non-Benzodiazepines Market Size Market Share by Product Status (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Non-Benzodiazepines Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Non-Benzodiazepines Market Size by Application (2021-2026)
8.3.2 World Non-Benzodiazepines Market Size by Application (2027-2032)
8.3.3 World Non-Benzodiazepines Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Cosette Pharmaceuticals
9.1.1 Cosette Pharmaceuticals Details
9.1.2 Cosette Pharmaceuticals Major Business
9.1.3 Cosette Pharmaceuticals Non-Benzodiazepines Product and Services
9.1.4 Cosette Pharmaceuticals Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Cosette Pharmaceuticals Recent Developments/Updates
9.1.6 Cosette Pharmaceuticals Competitive Strengths & Weaknesses
9.2 Sanofi
9.2.1 Sanofi Details
9.2.2 Sanofi Major Business
9.2.3 Sanofi Non-Benzodiazepines Product and Services
9.2.4 Sanofi Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Sanofi Recent Developments/Updates
9.2.6 Sanofi Competitive Strengths & Weaknesses
9.3 Sumitomo Pharma
9.3.1 Sumitomo Pharma Details
9.3.2 Sumitomo Pharma Major Business
9.3.3 Sumitomo Pharma Non-Benzodiazepines Product and Services
9.3.4 Sumitomo Pharma Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Sumitomo Pharma Recent Developments/Updates
9.3.6 Sumitomo Pharma Competitive Strengths & Weaknesses
9.4 Teva Pharmaceutical Industries
9.4.1 Teva Pharmaceutical Industries Details
9.4.2 Teva Pharmaceutical Industries Major Business
9.4.3 Teva Pharmaceutical Industries Non-Benzodiazepines Product and Services
9.4.4 Teva Pharmaceutical Industries Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.4.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.5 Viatris
9.5.1 Viatris Details
9.5.2 Viatris Major Business
9.5.3 Viatris Non-Benzodiazepines Product and Services
9.5.4 Viatris Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Viatris Recent Developments/Updates
9.5.6 Viatris Competitive Strengths & Weaknesses
9.6 Sandoz
9.6.1 Sandoz Details
9.6.2 Sandoz Major Business
9.6.3 Sandoz Non-Benzodiazepines Product and Services
9.6.4 Sandoz Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Sandoz Recent Developments/Updates
9.6.6 Sandoz Competitive Strengths & Weaknesses
9.7 Sun Pharmaceutical Industries
9.7.1 Sun Pharmaceutical Industries Details
9.7.2 Sun Pharmaceutical Industries Major Business
9.7.3 Sun Pharmaceutical Industries Non-Benzodiazepines Product and Services
9.7.4 Sun Pharmaceutical Industries Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Sun Pharmaceutical Industries Recent Developments/Updates
9.7.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
9.8 Dr. Reddy's Laboratories
9.8.1 Dr. Reddy's Laboratories Details
9.8.2 Dr. Reddy's Laboratories Major Business
9.8.3 Dr. Reddy's Laboratories Non-Benzodiazepines Product and Services
9.8.4 Dr. Reddy's Laboratories Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Dr. Reddy's Laboratories Recent Developments/Updates
9.8.6 Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
9.9 Aurobindo Pharma
9.9.1 Aurobindo Pharma Details
9.9.2 Aurobindo Pharma Major Business
9.9.3 Aurobindo Pharma Non-Benzodiazepines Product and Services
9.9.4 Aurobindo Pharma Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Aurobindo Pharma Recent Developments/Updates
9.9.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.10 Lupin
9.10.1 Lupin Details
9.10.2 Lupin Major Business
9.10.3 Lupin Non-Benzodiazepines Product and Services
9.10.4 Lupin Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Lupin Recent Developments/Updates
9.10.6 Lupin Competitive Strengths & Weaknesses
9.11 Torrent Pharmaceuticals
9.11.1 Torrent Pharmaceuticals Details
9.11.2 Torrent Pharmaceuticals Major Business
9.11.3 Torrent Pharmaceuticals Non-Benzodiazepines Product and Services
9.11.4 Torrent Pharmaceuticals Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Torrent Pharmaceuticals Recent Developments/Updates
9.11.6 Torrent Pharmaceuticals Competitive Strengths & Weaknesses
9.12 Jiangsu Nhwa Pharmaceutical
9.12.1 Jiangsu Nhwa Pharmaceutical Details
9.12.2 Jiangsu Nhwa Pharmaceutical Major Business
9.12.3 Jiangsu Nhwa Pharmaceutical Non-Benzodiazepines Product and Services
9.12.4 Jiangsu Nhwa Pharmaceutical Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
9.12.6 Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
9.13 Shanghai Pharmaceuticals
9.13.1 Shanghai Pharmaceuticals Details
9.13.2 Shanghai Pharmaceuticals Major Business
9.13.3 Shanghai Pharmaceuticals Non-Benzodiazepines Product and Services
9.13.4 Shanghai Pharmaceuticals Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Shanghai Pharmaceuticals Recent Developments/Updates
9.13.6 Shanghai Pharmaceuticals Competitive Strengths & Weaknesses
9.14 Qilu Pharmaceutical
9.14.1 Qilu Pharmaceutical Details
9.14.2 Qilu Pharmaceutical Major Business
9.14.3 Qilu Pharmaceutical Non-Benzodiazepines Product and Services
9.14.4 Qilu Pharmaceutical Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Qilu Pharmaceutical Recent Developments/Updates
9.14.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
9.15 Chengdu Kanghong Pharmaceutical Group
9.15.1 Chengdu Kanghong Pharmaceutical Group Details
9.15.2 Chengdu Kanghong Pharmaceutical Group Major Business
9.15.3 Chengdu Kanghong Pharmaceutical Group Non-Benzodiazepines Product and Services
9.15.4 Chengdu Kanghong Pharmaceutical Group Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
9.15.6 Chengdu Kanghong Pharmaceutical Group Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Non-Benzodiazepines Industry Chain
10.2 Non-Benzodiazepines Upstream Analysis
10.3 Non-Benzodiazepines Midstream Analysis
10.4 Non-Benzodiazepines Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Non-Benzodiazepines Introduction
1.2 World Non-Benzodiazepines Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Non-Benzodiazepines Total Market by Region (by Headquarter Location)
1.3.1 World Non-Benzodiazepines Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Non-Benzodiazepines Revenue (2021-2032)
1.3.3 China Based Company Non-Benzodiazepines Revenue (2021-2032)
1.3.4 Europe Based Company Non-Benzodiazepines Revenue (2021-2032)
1.3.5 Japan Based Company Non-Benzodiazepines Revenue (2021-2032)
1.3.6 South Korea Based Company Non-Benzodiazepines Revenue (2021-2032)
1.3.7 ASEAN Based Company Non-Benzodiazepines Revenue (2021-2032)
1.3.8 India Based Company Non-Benzodiazepines Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-Benzodiazepines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Non-Benzodiazepines Consumption Value (2021-2032)
2.2 World Non-Benzodiazepines Consumption Value by Region
2.2.1 World Non-Benzodiazepines Consumption Value by Region (2021-2026)
2.2.2 World Non-Benzodiazepines Consumption Value Forecast by Region (2027-2032)
2.3 United States Non-Benzodiazepines Consumption Value (2021-2032)
2.4 China Non-Benzodiazepines Consumption Value (2021-2032)
2.5 Europe Non-Benzodiazepines Consumption Value (2021-2032)
2.6 Japan Non-Benzodiazepines Consumption Value (2021-2032)
2.7 South Korea Non-Benzodiazepines Consumption Value (2021-2032)
2.8 ASEAN Non-Benzodiazepines Consumption Value (2021-2032)
2.9 India Non-Benzodiazepines Consumption Value (2021-2032)
3 WORLD NON-BENZODIAZEPINES COMPANIES COMPETITIVE ANALYSIS
3.1 World Non-Benzodiazepines Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Non-Benzodiazepines Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Non-Benzodiazepines in 2025
3.2.3 Global Concentration Ratios (CR8) for Non-Benzodiazepines in 2025
3.3 Non-Benzodiazepines Company Evaluation Quadrant
3.4 Non-Benzodiazepines Market: Overall Company Footprint Analysis
3.4.1 Non-Benzodiazepines Market: Region Footprint
3.4.2 Non-Benzodiazepines Market: Company Product Type Footprint
3.4.3 Non-Benzodiazepines Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Non-Benzodiazepines Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Non-Benzodiazepines Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Non-Benzodiazepines Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Non-Benzodiazepines Consumption Value Comparison
4.2.1 United States VS China: Non-Benzodiazepines Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Non-Benzodiazepines Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Non-Benzodiazepines Companies and Market Share, 2021-2026
4.3.1 United States Based Non-Benzodiazepines Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Non-Benzodiazepines Revenue, (2021-2026)
4.4 China Based Companies Non-Benzodiazepines Revenue and Market Share, 2021-2026
4.4.1 China Based Non-Benzodiazepines Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Non-Benzodiazepines Revenue, (2021-2026)
4.5 Rest of World Based Non-Benzodiazepines Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Non-Benzodiazepines Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Non-Benzodiazepines Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Non-Benzodiazepines Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Zolpidem
5.2.2 Zopiclone
5.2.3 Eszopiclone
5.2.4 Zaleplon
5.3 Market Segment by Type
5.3.1 World Non-Benzodiazepines Market Size by Type (2021-2026)
5.3.2 World Non-Benzodiazepines Market Size by Type (2027-2032)
5.3.3 World Non-Benzodiazepines Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DOSAGE FORM
6.1 World Non-Benzodiazepines Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage Form
6.2.1 Tablets
6.2.2 Capsules
6.2.3 Other
6.3 Market Segment by Dosage Form
6.3.1 World Non-Benzodiazepines Market Size by Dosage Form (2021-2026)
6.3.2 World Non-Benzodiazepines Market Size by Dosage Form (2027-2032)
6.3.3 World Non-Benzodiazepines Market Size Market Share by Dosage Form (2027-2032)
7 MARKET ANALYSIS BY PRODUCT STATUS
7.1 World Non-Benzodiazepines Market Size Overview by Product Status: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Status
7.2.1 Originator Drugs
7.2.2 Generic Drugs
7.3 Market Segment by Product Status
7.3.1 World Non-Benzodiazepines Market Size by Product Status (2021-2026)
7.3.2 World Non-Benzodiazepines Market Size by Product Status (2027-2032)
7.3.3 World Non-Benzodiazepines Market Size Market Share by Product Status (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Non-Benzodiazepines Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Non-Benzodiazepines Market Size by Application (2021-2026)
8.3.2 World Non-Benzodiazepines Market Size by Application (2027-2032)
8.3.3 World Non-Benzodiazepines Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Cosette Pharmaceuticals
9.1.1 Cosette Pharmaceuticals Details
9.1.2 Cosette Pharmaceuticals Major Business
9.1.3 Cosette Pharmaceuticals Non-Benzodiazepines Product and Services
9.1.4 Cosette Pharmaceuticals Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Cosette Pharmaceuticals Recent Developments/Updates
9.1.6 Cosette Pharmaceuticals Competitive Strengths & Weaknesses
9.2 Sanofi
9.2.1 Sanofi Details
9.2.2 Sanofi Major Business
9.2.3 Sanofi Non-Benzodiazepines Product and Services
9.2.4 Sanofi Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Sanofi Recent Developments/Updates
9.2.6 Sanofi Competitive Strengths & Weaknesses
9.3 Sumitomo Pharma
9.3.1 Sumitomo Pharma Details
9.3.2 Sumitomo Pharma Major Business
9.3.3 Sumitomo Pharma Non-Benzodiazepines Product and Services
9.3.4 Sumitomo Pharma Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Sumitomo Pharma Recent Developments/Updates
9.3.6 Sumitomo Pharma Competitive Strengths & Weaknesses
9.4 Teva Pharmaceutical Industries
9.4.1 Teva Pharmaceutical Industries Details
9.4.2 Teva Pharmaceutical Industries Major Business
9.4.3 Teva Pharmaceutical Industries Non-Benzodiazepines Product and Services
9.4.4 Teva Pharmaceutical Industries Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.4.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.5 Viatris
9.5.1 Viatris Details
9.5.2 Viatris Major Business
9.5.3 Viatris Non-Benzodiazepines Product and Services
9.5.4 Viatris Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Viatris Recent Developments/Updates
9.5.6 Viatris Competitive Strengths & Weaknesses
9.6 Sandoz
9.6.1 Sandoz Details
9.6.2 Sandoz Major Business
9.6.3 Sandoz Non-Benzodiazepines Product and Services
9.6.4 Sandoz Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Sandoz Recent Developments/Updates
9.6.6 Sandoz Competitive Strengths & Weaknesses
9.7 Sun Pharmaceutical Industries
9.7.1 Sun Pharmaceutical Industries Details
9.7.2 Sun Pharmaceutical Industries Major Business
9.7.3 Sun Pharmaceutical Industries Non-Benzodiazepines Product and Services
9.7.4 Sun Pharmaceutical Industries Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Sun Pharmaceutical Industries Recent Developments/Updates
9.7.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
9.8 Dr. Reddy's Laboratories
9.8.1 Dr. Reddy's Laboratories Details
9.8.2 Dr. Reddy's Laboratories Major Business
9.8.3 Dr. Reddy's Laboratories Non-Benzodiazepines Product and Services
9.8.4 Dr. Reddy's Laboratories Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Dr. Reddy's Laboratories Recent Developments/Updates
9.8.6 Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
9.9 Aurobindo Pharma
9.9.1 Aurobindo Pharma Details
9.9.2 Aurobindo Pharma Major Business
9.9.3 Aurobindo Pharma Non-Benzodiazepines Product and Services
9.9.4 Aurobindo Pharma Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Aurobindo Pharma Recent Developments/Updates
9.9.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.10 Lupin
9.10.1 Lupin Details
9.10.2 Lupin Major Business
9.10.3 Lupin Non-Benzodiazepines Product and Services
9.10.4 Lupin Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Lupin Recent Developments/Updates
9.10.6 Lupin Competitive Strengths & Weaknesses
9.11 Torrent Pharmaceuticals
9.11.1 Torrent Pharmaceuticals Details
9.11.2 Torrent Pharmaceuticals Major Business
9.11.3 Torrent Pharmaceuticals Non-Benzodiazepines Product and Services
9.11.4 Torrent Pharmaceuticals Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Torrent Pharmaceuticals Recent Developments/Updates
9.11.6 Torrent Pharmaceuticals Competitive Strengths & Weaknesses
9.12 Jiangsu Nhwa Pharmaceutical
9.12.1 Jiangsu Nhwa Pharmaceutical Details
9.12.2 Jiangsu Nhwa Pharmaceutical Major Business
9.12.3 Jiangsu Nhwa Pharmaceutical Non-Benzodiazepines Product and Services
9.12.4 Jiangsu Nhwa Pharmaceutical Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
9.12.6 Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
9.13 Shanghai Pharmaceuticals
9.13.1 Shanghai Pharmaceuticals Details
9.13.2 Shanghai Pharmaceuticals Major Business
9.13.3 Shanghai Pharmaceuticals Non-Benzodiazepines Product and Services
9.13.4 Shanghai Pharmaceuticals Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Shanghai Pharmaceuticals Recent Developments/Updates
9.13.6 Shanghai Pharmaceuticals Competitive Strengths & Weaknesses
9.14 Qilu Pharmaceutical
9.14.1 Qilu Pharmaceutical Details
9.14.2 Qilu Pharmaceutical Major Business
9.14.3 Qilu Pharmaceutical Non-Benzodiazepines Product and Services
9.14.4 Qilu Pharmaceutical Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Qilu Pharmaceutical Recent Developments/Updates
9.14.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
9.15 Chengdu Kanghong Pharmaceutical Group
9.15.1 Chengdu Kanghong Pharmaceutical Group Details
9.15.2 Chengdu Kanghong Pharmaceutical Group Major Business
9.15.3 Chengdu Kanghong Pharmaceutical Group Non-Benzodiazepines Product and Services
9.15.4 Chengdu Kanghong Pharmaceutical Group Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
9.15.6 Chengdu Kanghong Pharmaceutical Group Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Non-Benzodiazepines Industry Chain
10.2 Non-Benzodiazepines Upstream Analysis
10.3 Non-Benzodiazepines Midstream Analysis
10.4 Non-Benzodiazepines Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Non-Benzodiazepines Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Non-Benzodiazepines Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Non-Benzodiazepines Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Non-Benzodiazepines Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Non-Benzodiazepines Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Non-Benzodiazepines Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Non-Benzodiazepines Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Non-Benzodiazepines Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Non-Benzodiazepines Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Non-Benzodiazepines Players in 2025
Table 12. World Non-Benzodiazepines Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Non-Benzodiazepines Company Evaluation Quadrant
Table 14. Head Office of Key Non-Benzodiazepines Players
Table 15. Non-Benzodiazepines Market: Company Product Type Footprint
Table 16. Non-Benzodiazepines Market: Company Product Application Footprint
Table 17. Non-Benzodiazepines Mergers & Acquisitions Activity
Table 18. United States VS China Non-Benzodiazepines Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Non-Benzodiazepines Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Non-Benzodiazepines Companies, Headquarters (States, Country)
Table 21. United States Based Companies Non-Benzodiazepines Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Non-Benzodiazepines Revenue Market Share (2021-2026)
Table 23. China Based Non-Benzodiazepines Companies, Headquarters (Province, Country)
Table 24. China Based Companies Non-Benzodiazepines Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Non-Benzodiazepines Revenue Market Share (2021-2026)
Table 26. Rest of World Based Non-Benzodiazepines Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Non-Benzodiazepines Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Non-Benzodiazepines Revenue Market Share (2021-2026)
Table 29. World Non-Benzodiazepines Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Non-Benzodiazepines Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Non-Benzodiazepines Market Size by Type (2027-2032) & (USD Million)
Table 32. World Non-Benzodiazepines Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 33. World Non-Benzodiazepines Market Size Value by Dosage Form (2021-2026) & (USD Million)
Table 34. World Non-Benzodiazepines Market Size by Dosage Form (2027-2032) & (USD Million)
Table 35. World Non-Benzodiazepines Market Size by Product Status, (USD Million), 2021 & 2025 & 2032
Table 36. World Non-Benzodiazepines Market Size Value by Product Status (2021-2026) & (USD Million)
Table 37. World Non-Benzodiazepines Market Size by Product Status (2027-2032) & (USD Million)
Table 38. World Non-Benzodiazepines Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Non-Benzodiazepines Market Size by Application (2021-2026) & (USD Million)
Table 40. World Non-Benzodiazepines Market Size by Application (2027-2032) & (USD Million)
Table 41. Cosette Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 42. Cosette Pharmaceuticals Major Business
Table 43. Cosette Pharmaceuticals Non-Benzodiazepines Product and Services
Table 44. Cosette Pharmaceuticals Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Cosette Pharmaceuticals Recent Developments/Updates
Table 46. Cosette Pharmaceuticals Competitive Strengths & Weaknesses
Table 47. Sanofi Basic Information, Manufacturing Base and Competitors
Table 48. Sanofi Major Business
Table 49. Sanofi Non-Benzodiazepines Product and Services
Table 50. Sanofi Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Sanofi Recent Developments/Updates
Table 52. Sanofi Competitive Strengths & Weaknesses
Table 53. Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Sumitomo Pharma Major Business
Table 55. Sumitomo Pharma Non-Benzodiazepines Product and Services
Table 56. Sumitomo Pharma Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Sumitomo Pharma Recent Developments/Updates
Table 58. Sumitomo Pharma Competitive Strengths & Weaknesses
Table 59. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 60. Teva Pharmaceutical Industries Major Business
Table 61. Teva Pharmaceutical Industries Non-Benzodiazepines Product and Services
Table 62. Teva Pharmaceutical Industries Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Teva Pharmaceutical Industries Recent Developments/Updates
Table 64. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 65. Viatris Basic Information, Manufacturing Base and Competitors
Table 66. Viatris Major Business
Table 67. Viatris Non-Benzodiazepines Product and Services
Table 68. Viatris Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Viatris Recent Developments/Updates
Table 70. Viatris Competitive Strengths & Weaknesses
Table 71. Sandoz Basic Information, Manufacturing Base and Competitors
Table 72. Sandoz Major Business
Table 73. Sandoz Non-Benzodiazepines Product and Services
Table 74. Sandoz Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Sandoz Recent Developments/Updates
Table 76. Sandoz Competitive Strengths & Weaknesses
Table 77. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 78. Sun Pharmaceutical Industries Major Business
Table 79. Sun Pharmaceutical Industries Non-Benzodiazepines Product and Services
Table 80. Sun Pharmaceutical Industries Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Sun Pharmaceutical Industries Recent Developments/Updates
Table 82. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 83. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 84. Dr. Reddy's Laboratories Major Business
Table 85. Dr. Reddy's Laboratories Non-Benzodiazepines Product and Services
Table 86. Dr. Reddy's Laboratories Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Dr. Reddy's Laboratories Recent Developments/Updates
Table 88. Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
Table 89. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 90. Aurobindo Pharma Major Business
Table 91. Aurobindo Pharma Non-Benzodiazepines Product and Services
Table 92. Aurobindo Pharma Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Aurobindo Pharma Recent Developments/Updates
Table 94. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 95. Lupin Basic Information, Manufacturing Base and Competitors
Table 96. Lupin Major Business
Table 97. Lupin Non-Benzodiazepines Product and Services
Table 98. Lupin Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Lupin Recent Developments/Updates
Table 100. Lupin Competitive Strengths & Weaknesses
Table 101. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 102. Torrent Pharmaceuticals Major Business
Table 103. Torrent Pharmaceuticals Non-Benzodiazepines Product and Services
Table 104. Torrent Pharmaceuticals Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Torrent Pharmaceuticals Recent Developments/Updates
Table 106. Torrent Pharmaceuticals Competitive Strengths & Weaknesses
Table 107. Jiangsu Nhwa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 108. Jiangsu Nhwa Pharmaceutical Major Business
Table 109. Jiangsu Nhwa Pharmaceutical Non-Benzodiazepines Product and Services
Table 110. Jiangsu Nhwa Pharmaceutical Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
Table 112. Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
Table 113. Shanghai Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 114. Shanghai Pharmaceuticals Major Business
Table 115. Shanghai Pharmaceuticals Non-Benzodiazepines Product and Services
Table 116. Shanghai Pharmaceuticals Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Shanghai Pharmaceuticals Recent Developments/Updates
Table 118. Shanghai Pharmaceuticals Competitive Strengths & Weaknesses
Table 119. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 120. Qilu Pharmaceutical Major Business
Table 121. Qilu Pharmaceutical Non-Benzodiazepines Product and Services
Table 122. Qilu Pharmaceutical Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Qilu Pharmaceutical Recent Developments/Updates
Table 124. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 125. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 126. Chengdu Kanghong Pharmaceutical Group Major Business
Table 127. Chengdu Kanghong Pharmaceutical Group Non-Benzodiazepines Product and Services
Table 128. Chengdu Kanghong Pharmaceutical Group Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 130. Chengdu Kanghong Pharmaceutical Group Competitive Strengths & Weaknesses
Table 131. Global Key Players of Non-Benzodiazepines Upstream (Raw Materials)
Table 132. Global Non-Benzodiazepines Typical Customers
Table 1. World Non-Benzodiazepines Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Non-Benzodiazepines Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Non-Benzodiazepines Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Non-Benzodiazepines Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Non-Benzodiazepines Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Non-Benzodiazepines Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Non-Benzodiazepines Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Non-Benzodiazepines Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Non-Benzodiazepines Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Non-Benzodiazepines Players in 2025
Table 12. World Non-Benzodiazepines Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Non-Benzodiazepines Company Evaluation Quadrant
Table 14. Head Office of Key Non-Benzodiazepines Players
Table 15. Non-Benzodiazepines Market: Company Product Type Footprint
Table 16. Non-Benzodiazepines Market: Company Product Application Footprint
Table 17. Non-Benzodiazepines Mergers & Acquisitions Activity
Table 18. United States VS China Non-Benzodiazepines Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Non-Benzodiazepines Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Non-Benzodiazepines Companies, Headquarters (States, Country)
Table 21. United States Based Companies Non-Benzodiazepines Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Non-Benzodiazepines Revenue Market Share (2021-2026)
Table 23. China Based Non-Benzodiazepines Companies, Headquarters (Province, Country)
Table 24. China Based Companies Non-Benzodiazepines Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Non-Benzodiazepines Revenue Market Share (2021-2026)
Table 26. Rest of World Based Non-Benzodiazepines Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Non-Benzodiazepines Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Non-Benzodiazepines Revenue Market Share (2021-2026)
Table 29. World Non-Benzodiazepines Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Non-Benzodiazepines Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Non-Benzodiazepines Market Size by Type (2027-2032) & (USD Million)
Table 32. World Non-Benzodiazepines Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 33. World Non-Benzodiazepines Market Size Value by Dosage Form (2021-2026) & (USD Million)
Table 34. World Non-Benzodiazepines Market Size by Dosage Form (2027-2032) & (USD Million)
Table 35. World Non-Benzodiazepines Market Size by Product Status, (USD Million), 2021 & 2025 & 2032
Table 36. World Non-Benzodiazepines Market Size Value by Product Status (2021-2026) & (USD Million)
Table 37. World Non-Benzodiazepines Market Size by Product Status (2027-2032) & (USD Million)
Table 38. World Non-Benzodiazepines Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Non-Benzodiazepines Market Size by Application (2021-2026) & (USD Million)
Table 40. World Non-Benzodiazepines Market Size by Application (2027-2032) & (USD Million)
Table 41. Cosette Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 42. Cosette Pharmaceuticals Major Business
Table 43. Cosette Pharmaceuticals Non-Benzodiazepines Product and Services
Table 44. Cosette Pharmaceuticals Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Cosette Pharmaceuticals Recent Developments/Updates
Table 46. Cosette Pharmaceuticals Competitive Strengths & Weaknesses
Table 47. Sanofi Basic Information, Manufacturing Base and Competitors
Table 48. Sanofi Major Business
Table 49. Sanofi Non-Benzodiazepines Product and Services
Table 50. Sanofi Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Sanofi Recent Developments/Updates
Table 52. Sanofi Competitive Strengths & Weaknesses
Table 53. Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Sumitomo Pharma Major Business
Table 55. Sumitomo Pharma Non-Benzodiazepines Product and Services
Table 56. Sumitomo Pharma Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Sumitomo Pharma Recent Developments/Updates
Table 58. Sumitomo Pharma Competitive Strengths & Weaknesses
Table 59. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 60. Teva Pharmaceutical Industries Major Business
Table 61. Teva Pharmaceutical Industries Non-Benzodiazepines Product and Services
Table 62. Teva Pharmaceutical Industries Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Teva Pharmaceutical Industries Recent Developments/Updates
Table 64. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 65. Viatris Basic Information, Manufacturing Base and Competitors
Table 66. Viatris Major Business
Table 67. Viatris Non-Benzodiazepines Product and Services
Table 68. Viatris Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Viatris Recent Developments/Updates
Table 70. Viatris Competitive Strengths & Weaknesses
Table 71. Sandoz Basic Information, Manufacturing Base and Competitors
Table 72. Sandoz Major Business
Table 73. Sandoz Non-Benzodiazepines Product and Services
Table 74. Sandoz Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Sandoz Recent Developments/Updates
Table 76. Sandoz Competitive Strengths & Weaknesses
Table 77. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 78. Sun Pharmaceutical Industries Major Business
Table 79. Sun Pharmaceutical Industries Non-Benzodiazepines Product and Services
Table 80. Sun Pharmaceutical Industries Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Sun Pharmaceutical Industries Recent Developments/Updates
Table 82. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 83. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 84. Dr. Reddy's Laboratories Major Business
Table 85. Dr. Reddy's Laboratories Non-Benzodiazepines Product and Services
Table 86. Dr. Reddy's Laboratories Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Dr. Reddy's Laboratories Recent Developments/Updates
Table 88. Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
Table 89. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 90. Aurobindo Pharma Major Business
Table 91. Aurobindo Pharma Non-Benzodiazepines Product and Services
Table 92. Aurobindo Pharma Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Aurobindo Pharma Recent Developments/Updates
Table 94. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 95. Lupin Basic Information, Manufacturing Base and Competitors
Table 96. Lupin Major Business
Table 97. Lupin Non-Benzodiazepines Product and Services
Table 98. Lupin Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Lupin Recent Developments/Updates
Table 100. Lupin Competitive Strengths & Weaknesses
Table 101. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 102. Torrent Pharmaceuticals Major Business
Table 103. Torrent Pharmaceuticals Non-Benzodiazepines Product and Services
Table 104. Torrent Pharmaceuticals Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Torrent Pharmaceuticals Recent Developments/Updates
Table 106. Torrent Pharmaceuticals Competitive Strengths & Weaknesses
Table 107. Jiangsu Nhwa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 108. Jiangsu Nhwa Pharmaceutical Major Business
Table 109. Jiangsu Nhwa Pharmaceutical Non-Benzodiazepines Product and Services
Table 110. Jiangsu Nhwa Pharmaceutical Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
Table 112. Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
Table 113. Shanghai Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 114. Shanghai Pharmaceuticals Major Business
Table 115. Shanghai Pharmaceuticals Non-Benzodiazepines Product and Services
Table 116. Shanghai Pharmaceuticals Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Shanghai Pharmaceuticals Recent Developments/Updates
Table 118. Shanghai Pharmaceuticals Competitive Strengths & Weaknesses
Table 119. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 120. Qilu Pharmaceutical Major Business
Table 121. Qilu Pharmaceutical Non-Benzodiazepines Product and Services
Table 122. Qilu Pharmaceutical Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Qilu Pharmaceutical Recent Developments/Updates
Table 124. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 125. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 126. Chengdu Kanghong Pharmaceutical Group Major Business
Table 127. Chengdu Kanghong Pharmaceutical Group Non-Benzodiazepines Product and Services
Table 128. Chengdu Kanghong Pharmaceutical Group Non-Benzodiazepines Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 130. Chengdu Kanghong Pharmaceutical Group Competitive Strengths & Weaknesses
Table 131. Global Key Players of Non-Benzodiazepines Upstream (Raw Materials)
Table 132. Global Non-Benzodiazepines Typical Customers
LIST OF FIGURES
Figure 1. Non-Benzodiazepines Picture
Figure 2. World Non-Benzodiazepines Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Non-Benzodiazepines Total Revenue (2021-2032) & (USD Million)
Figure 4. World Non-Benzodiazepines Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Non-Benzodiazepines Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Non-Benzodiazepines Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Non-Benzodiazepines Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Non-Benzodiazepines Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Non-Benzodiazepines Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Non-Benzodiazepines Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Non-Benzodiazepines Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Non-Benzodiazepines Revenue (2021-2032) & (USD Million)
Figure 13. Non-Benzodiazepines Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Non-Benzodiazepines Consumption Value (2021-2032) & (USD Million)
Figure 16. World Non-Benzodiazepines Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Non-Benzodiazepines Consumption Value (2021-2032) & (USD Million)
Figure 18. China Non-Benzodiazepines Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Non-Benzodiazepines Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Non-Benzodiazepines Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Non-Benzodiazepines Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Non-Benzodiazepines Consumption Value (2021-2032) & (USD Million)
Figure 23. India Non-Benzodiazepines Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Non-Benzodiazepines by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Non-Benzodiazepines Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Non-Benzodiazepines Markets in 2025
Figure 27. United States VS China: Non-Benzodiazepines Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Non-Benzodiazepines Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Non-Benzodiazepines Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Non-Benzodiazepines Market Size Market Share by Type in 2025
Figure 31. Zolpidem
Figure 32. Zopiclone
Figure 33. Eszopiclone
Figure 34. Zaleplon
Figure 35. World Non-Benzodiazepines Market Size Market Share by Type (2021-2032)
Figure 36. World Non-Benzodiazepines Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 37. World Non-Benzodiazepines Market Size Market Share by Dosage Form in 2025
Figure 38.Tablets
Figure 39. Capsules
Figure 40. Other
Figure 41. World Non-Benzodiazepines Market Size Market Share by Dosage Form (2021-2032)
Figure 42. World Non-Benzodiazepines Market Size by Product Status, (USD Million), 2021 & 2025 & 2032
Figure 43. World Non-Benzodiazepines Market Size Market Share by Product Status in 2025
Figure 44. Originator Drugs
Figure 45. Generic Drugs
Figure 46. World Non-Benzodiazepines Market Size Market Share by Product Status (2021-2032)
Figure 47. World Non-Benzodiazepines Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Non-Benzodiazepines Market Size Market Share by Application in 2025
Figure 49. Hospital
Figure 50. Clinic
Figure 51. Others
Figure 52. World Non-Benzodiazepines Market Size Market Share by Application (2021-2032)
Figure 53. Non-Benzodiazepines Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Non-Benzodiazepines Picture
Figure 2. World Non-Benzodiazepines Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Non-Benzodiazepines Total Revenue (2021-2032) & (USD Million)
Figure 4. World Non-Benzodiazepines Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Non-Benzodiazepines Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Non-Benzodiazepines Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Non-Benzodiazepines Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Non-Benzodiazepines Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Non-Benzodiazepines Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Non-Benzodiazepines Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Non-Benzodiazepines Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Non-Benzodiazepines Revenue (2021-2032) & (USD Million)
Figure 13. Non-Benzodiazepines Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Non-Benzodiazepines Consumption Value (2021-2032) & (USD Million)
Figure 16. World Non-Benzodiazepines Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Non-Benzodiazepines Consumption Value (2021-2032) & (USD Million)
Figure 18. China Non-Benzodiazepines Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Non-Benzodiazepines Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Non-Benzodiazepines Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Non-Benzodiazepines Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Non-Benzodiazepines Consumption Value (2021-2032) & (USD Million)
Figure 23. India Non-Benzodiazepines Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Non-Benzodiazepines by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Non-Benzodiazepines Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Non-Benzodiazepines Markets in 2025
Figure 27. United States VS China: Non-Benzodiazepines Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Non-Benzodiazepines Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Non-Benzodiazepines Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Non-Benzodiazepines Market Size Market Share by Type in 2025
Figure 31. Zolpidem
Figure 32. Zopiclone
Figure 33. Eszopiclone
Figure 34. Zaleplon
Figure 35. World Non-Benzodiazepines Market Size Market Share by Type (2021-2032)
Figure 36. World Non-Benzodiazepines Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 37. World Non-Benzodiazepines Market Size Market Share by Dosage Form in 2025
Figure 38.Tablets
Figure 39. Capsules
Figure 40. Other
Figure 41. World Non-Benzodiazepines Market Size Market Share by Dosage Form (2021-2032)
Figure 42. World Non-Benzodiazepines Market Size by Product Status, (USD Million), 2021 & 2025 & 2032
Figure 43. World Non-Benzodiazepines Market Size Market Share by Product Status in 2025
Figure 44. Originator Drugs
Figure 45. Generic Drugs
Figure 46. World Non-Benzodiazepines Market Size Market Share by Product Status (2021-2032)
Figure 47. World Non-Benzodiazepines Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Non-Benzodiazepines Market Size Market Share by Application in 2025
Figure 49. Hospital
Figure 50. Clinic
Figure 51. Others
Figure 52. World Non-Benzodiazepines Market Size Market Share by Application (2021-2032)
Figure 53. Non-Benzodiazepines Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
